Advances in Parkinson's Disease Drugs
- PMID: 34827638
- PMCID: PMC8615848
- DOI: 10.3390/biom11111640
Advances in Parkinson's Disease Drugs
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative age-related disorder worldwide after Alzheimer's disease [...].
Conflict of interest statement
The authors declare no conflict of interest.
Comment on
-
Role of Dietary Supplements in the Management of Parkinson's Disease.Biomolecules. 2019 Jul 10;9(7):271. doi: 10.3390/biom9070271. Biomolecules. 2019. PMID: 31295842 Free PMC article. Review.
References
-
- Laserra S., Basit A., Sozio P., Marinelli L., Fornasari E., Cacciatore I., Ciulla M., Türkez H., Geyikoglu F., Di Stefano A. Solid lipid nanoparticles loaded with lipoyl–memantine codrug: Preparation and characterization. Int. J. Pharm. 2015;485:183–191. doi: 10.1016/j.ijpharm.2015.03.001. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical